Notice on Completion of Payment for Issuance of New Shares Under Restricted Stock-linked Remuneration Program Posted Jul 26, 2018
Santen Receives Marketing Authorisation from the European Commission for DE-076C (Verkazia) as an Orphan Medicinal Product Posted Jul 10, 2018
Notice on the Issuance of New Shares Under Restricted Stock-Linked Remuneration Program Posted Jun 26, 2018
Notice on the Introduction of a New Stock-Linked Remuneration Program and Change to Director Remuneration Posted May 9, 2018
Santen to Conduct a Public Awareness Campaign for Glaucoma During World Glaucoma Week March 11 - 17 Posted Feb 23, 2018
